Both in Pharmaceuticals
Skye Bioscience vs Azitra
Over the past year SKYE returned −87.8% and AZTR returned −81.7%; their daily moves had a correlation of -0.02.
SKYE −87.8% AZTR −81.7%Growth of $1, one year, split-adjusted
| Metric | SKYE | AZTR |
|---|---|---|
| Price | $1.52 | $0.9046 |
| Market cap | $6.7M | $5.5M |
| Today | +4.83% | −19.23% |
| 1 month | −4.4% | −30.7% |
| 6 months | −78.7% | −63.8% |
| Year to date | −74.7% | −65.8% |
| 1 year | −88.2% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $9.9M | $6.7M |
| Dividend yield | — | — |
| Volatility (60d) | 617.0% | 217.8% |
| Short % of float | 0.6% | 0.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).